SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-063097
Filing Date
2020-03-05
Accepted
2020-03-05 16:16:02
Documents
3
Period of Report
2020-03-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d900669d8k.htm 8-K 17824
2 EX-99.1 d900669dex991.htm EX-99.1 85388
3 GRAPHIC g900669g0305071206756.jpg GRAPHIC 3263
  Complete submission text file 0001193125-20-063097.txt   109066
Mailing Address 3 CENTER PLAZA SUITE 610 BOSTON MA 02108
Business Address 3 CENTER PLAZA SUITE 610 BOSTON MA 02108 617-622-4003
ZAFGEN, INC. (Filer) CIK: 0001374690 (see all company filings)

IRS No.: 203857670 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36510 | Film No.: 20691001
SIC: 2834 Pharmaceutical Preparations